Open AccessChronic subdural hematomas: challenges and solutions. Part 2. New concept for treatment of chronic subdural hematomas and the results
Author(s) -
Л. Б. Лихтерман,
AUTHOR_ID,
А Д Кравчук,
В. А. Охлопков,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2021
Publication title -
kliničeskij razbor v obŝej medicine
Language(s) - English
Resource type - Journals
eISSN - 2782-5671
pISSN - 2713-2552
DOI - 10.47407/kr2021.2.3.00050
Subject(s) - chronic subdural hematoma , subdural hematomas , craniotomy , medicine , hematoma , fibrin , surgery , case fatality rate , anesthesia , epidemiology , immunology
The observed dramatic 6–60-fold increase in fibrin degradation product levels in the cSDH cavity compared to peripheral blood was the rationale that underpinned the development of new concept for treatment of chronic subdural hematoma. The minimally invasive surgery results are reported, demonstrating decrease in fatality rate from 12–18% to 1.2% compared to craniotomy, as well as disappearance of severe post-operative complications, such as cerebral collapse. According to 1–10-year follow-up data, 91.7% of patients have shown good recovery.